Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients

NCT02773355 · clinicaltrials.gov ↗

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: liraglutide 3.0 mg

Sponsor

Novo Nordisk A/S